Languages
Pages
Legal
Explore all categories to find your favorite topic
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S VO L 9 N O 8 2 0 1 6 ª 2 0 1 6 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D…
One-Year Clinical Outcome after Coronary Stenting of Very Small Vessels Using 2.25 mm Sirolimus-and Paclitaxel-Eluting StentsComparison of the Efficacy and Safety of Zotarolimus-Eluting
Drug-eluting stents HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21st February 2014 Drug-eluting stents Are they all equal? VassilisVassilis SpanosSpanos Interventional…
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael Maeng, Klaus Rasmussen,…
Slide 1SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael Maeng, Klaus…
Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel-Eluting…
Présentation PowerPointdual antiplatelet therapy duration. A pre-specified analysis from the The Zotarolimus- eluting Endeavor sprint stent in Uncertain DES candidates
1. Endeavor IV: A Randomized Comparison of a Zotarolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease Martin B. Leon, MDColumbia…
Jai Pal Singh Ph D Jai Pal Singh Ph D Chief Scientific Officer Chief Scientific Officer Vice President of ResearchVice President of Research SJTRI Atlanta GA USASJTRI Atlanta…
RESEARCH ARTICLE Open Access Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review…
INSTRUCTIONS FOR USE CAUTION - Federal (USA) law restricts this device for sale by or on the order of a physician. 97 Table of Contents I RESOLUTE INTEGRITY ZOTAROLIMUS ELUTING
Sirolimus-eluting Stents: Present and Future Dr Steve Fearn Director of Health Economics and Medical Affairs Cordis UK Conflict of Interest I am employed by Cordis. Topics…
The Detrimental Impact of Chronic Renal InsufficiencyProspective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed- Wire and Rapid-Exchange Delivery
Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System Rapid Exchange and Over-the-Wire Delivery Systems INSTRUCTIONS FOR USE CAUTION – Federal (USA) law restricts…
Microsoft PowerPoint - 3 Jung-Sun Kim_OCT (Kim JS)Kim, JungKim, Jung--Sun, M.D. Ph D. Sun, M.D. Ph D. Yonsei University College of Medicine,Yonsei University College of Medicine,
1. Estudio SORT OUT III Eficacia y seguridad de stents liberadores de zotarolimus y liberadores de sirolimus en la práctica clínica cotidiana: estudio aleatorizado de superioridad.…
P C R euro Randomized comparison of a sirolimus-eluting stent with a biolimus-eluting stent in patients treated with PCI: the SORT OUT VII trial Lisette Okkels Jensen, Per…
PowerPoint PresentationMeRes100 – Sirolimus Eluting BRS Design Features and Clinical Status Update Prof. Upendra Kaul MD, DM, FCSI, FSCAI, FACC, FAMS Executive Director
Slide 1Prospective, Randomized Trial of Paclitaxel- versus Sirolimus- Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents Robert A. Byrne, Julinda…
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 1 , N O . 4 , 2 0 0 8 © 2 0 0 8 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T…